Evidence map›Paper›PMID 37726734›Full record

ArticleBMC public health2023

Experiences of stigma and HIV care engagement in the context of Treat All in Rwanda: a qualitative study.

Charles Ingabire, Dana Watnick, Josephine Gasana, Francine Umwiza, Athanase Munyaneza, Gallican Kubwimana, Gad Murenzi, Kathryn Anastos, Adebola Adedimeji, Jonathan Ross

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Charles IngabireEinstein-Rwanda Research and Capacity Building Program, Rwanda Military Hospital, Kigali, Rwanda. chazk.ingabire@gmail.com.
Dana WatnickDepartment of Pediatrics, Albert Einstein College of Medicine, Bronx, NY, USA.
Josephine GasanaEinstein-Rwanda Research and Capacity Building Program, Rwanda Military Hospital, Kigali, Rwanda.
Francine UmwizaEinstein-Rwanda Research and Capacity Building Program, Rwanda Military Hospital, Kigali, Rwanda.
Athanase MunyanezaEinstein-Rwanda Research and Capacity Building Program, Rwanda Military Hospital, Kigali, Rwanda.
Gallican KubwimanaEinstein-Rwanda Research and Capacity Building Program, Rwanda Military Hospital, Kigali, Rwanda.
Gad MurenziEinstein-Rwanda Research and Capacity Building Program, Rwanda Military Hospital, Kigali, Rwanda.
Kathryn AnastosDepartment of Medicine, Albert Einstein College of Medicine, Bronx, NY, USA.
Adebola AdedimejiDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
Jonathan RossDepartment of Medicine, Albert Einstein College of Medicine, Bronx, NY, USA.
Albert Einstein College of Medicine · USRwanda Military Hospital · RWRwanda Development Board · RW

Funding

"Enhancing Cancer Research in Central Africa IeDEA"U01AI096299 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI Denis Nash, Marcel Yotebieng · 2011 to 2026
$35.8M
Patient and Population Health Outcomes Research SWGP30AI124414 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI Joan Weinberger Berman · 2017 to 2026
$28.3M
Minimizing losses from HIV care under universal treatment in RwandaK23MH114752 · NIMH · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI ROSS, JONATHAN · 2017 to 2021
$995k
NIAID NIH HHS U01 AI096299NIMH NIH HHS K23 MH114752
6 · The paper itself

Abstract

background'Treat All' policies recommending immediate antiretroviral therapy (ART) soon after HIV diagnosis for all people living with HIV (PLHIV) are now ubiquitous in sub-Saharan Africa. While early ART initiation and retention is effective at curtailing disease progression and transmission, evidence suggests that stigma may act as a barrier to engagement in care. This study sought to understand the relationships between HIV stigma and engagement in care for PLHIV in Rwanda in the context of Treat All.

methodsBetween September 2018 and March 2019, we conducted semi-structured, qualitative interviews with adult PLHIV receiving care at two health centers in Kigali, Rwanda. We used a grounded theory approach to data analysis to develop conceptual framework describing how stigma influences HIV care engagement in the context of early Treat All policy implementation in Rwanda.

resultsAmong 37 participants, 27 (73%) were women and the median age was 31 years. Participants described how care engagement under Treat All, including taking medications and attending appointments, increased their visibility as PLHIV. This served to normalize HIV and use of ART but also led to high levels of anticipated stigma in the health center and community at early stages of treatment. Enacted stigma from family and community members and resultant internalized stigma acted as additional barriers to care engagement. Nonetheless, participants described how psychosocial support from care providers and family members helped them cope with stigma and promoted continued engagement in care.

conclusionsTreat All policy in Rwanda has heightened the visibility of HIV at the individual and social levels, which has influenced HIV stigma, normalization, psychosocial support and care engagement in complex ways. Leveraging the individual and community support described by PLHIV to deliver evidence-based, peer or provider-delivered stigma reduction interventions may aid in attaining Treat All goals.

Indexed as

CognitionCommunity SupportAdultData AnalysisFemaleHumansMaleQualitative ResearchRwandaHIV status visibilityHIV stigmaHIV TestingPsychosocial SupportQualitative ResearchTreat AllTreatment adherence and compliance

Identifiers

PMID37726734
PMCPMC10507909
OpenAlexW4386850391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.